Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
ACS Nano|March 11, 2024
Multiple Immunomodulatory Strategies Based on Targeted Regulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Immune Homeostasis against Hepatocellular CarcinomaShiji Fang, Liyun Zheng, Gao-Feng Shu, et al.Asian Journal of Pharmaceutical Sciences|April 10, 2024
Acidic/hypoxia dual-alleviated nanoregulators for enhanced treatment of tumor chemo-immunotherapyXiaoju Guo, Xiaoxiao Chen, Jiayi Ding, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 23, 2022
Integrated application of transcriptome and metabolomics reveals potential therapeutic targets for the polarization of atherosclerotic macrophagesLin Shen, Han Li, Weiqian Chen, et al.Physical Review Letters|July 16, 2013
Dynamics of glass relaxation at room temperatureRoger C Welch, John R Smith, Marcel Potuzak, et al.Acta Biomaterialia|April 24, 2025
Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptorMinjiang Chen, Yaning Chen, Weiqian Chen, et al.ACS Nano|September 29, 2024
Potentiated Calcium Carbonate with Enhanced Calcium Overload Induction and Acid Neutralization Capabilities to Boost Chemoimmunotherapy against Liver CancerLiyun Zheng, Yiming Ding, Shiji Fang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2025
Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular CarcinomaShiji Fang, Liyun Zheng, Bin Lin, et al.Nature Communications|December 19, 2023
NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathwayShuzhi Cui, Tian Xia, Jianjin Zhao, et al.Pageof 2